NRG Oncology highlighted at #ASTRO19 with 4 Plenary Session talks featuring NRG Oncology resarch. Read more
CLOSURES AND SUSPENSIONS
NRG-BR002: Temporarily closed to accrual, effective September 13, 2019. Please refer to the memo posted on CTSU for further details.
RTOG 1119: Study Closure Memorandum dated September 12, 2019 (posted to CTSU)
NRG-GU006 Sites in Canada only: Amendment 3 has been approved by Health Canada. The NOL and relevant forms are posted on the CTSU website. In addition, please be sure to complete and submit the updated IB and protocol signature pages to CTSU.
OTHER PROTOCOL NOTICES
NRG-GY005: CEC Whole Blood Shipping Address memo (posted on CTSU)
NRG-GY009: Block Submission Reminder memo (posted on CTSU)
Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more
Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more
2. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, October 9.
DRUG SAFETY UPDATES
Safety updates have been issued for the following studies:
WEBSITE FOR SAFETY REPORTS
NRG Oncology at #ASTRO19
Results from twenty-one NRG Oncology clinical trials are being presented at the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago, Illinois being held September 15-18. All four ASTRO Plenary Session presentations are featuring NRG Oncology research, and these four highly impactful projects were chosen from over 3,000 submitted abstracts. The NRG Oncology presentations at the meeting will include results from trials for patients with brain tumors, spine metastases, or anal, breast, cervix, genitourinary, gynecologic, head and neck, liver, lung, or prostate cancer. Read more
Please note the following upcoming meeting and abstract submission deadline dates